According to Organogenesis's latest financial reports the company's current EPS (TTM) is $0.08164. In 2022 the company made an earnings per share (EPS) of $0.12 a decrease over its 2021 EPS that were of $0.74.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.08164 | -32.88% |
2022 | $0.12 | -83.56% |
2021 | $0.74 | 393.33% |
2020 | $0.15 | -134.09% |
2019 | -$0.44 | -54.17% |
2018 | -$0.96 | 97.96% |
2017 | -$0.48 | 10.28% |
2016 | -$0.44 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.27 | -430.71% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$1.00 | -1,324.86% | ๐บ๐ธ USA |